Works in Cancer Chemotherapy & Pharmacology, 2017, Vol 80, Issue 2
Results: 23
Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Assessment of cabozantinib treatment on QT interval in a phase 3 study in medullary thyroid cancer: evaluation of indirect QT effects mediated through treatment-induced changes in serum electrolytes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A randomized phase II study of gemcitabine plus Z-360, a CCK2 receptor-selective antagonist, in patients with metastatic pancreatic cancer as compared with gemcitabine plus placebo.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Genetic variability in the regulation of the expression cluster of MDR genes in patients with breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Knockdown of long non-coding RNA KCNQ1OT1 depressed chemoresistance to paclitaxel in lung adenocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Intracellular vorinostat accumulation and its relationship to histone deacetylase activity in soft tissue sarcoma patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Involvement of cytochrome P450 in cisplatin treatment: implications for toxicity.
- Published in:
- 2017
- By:
- Publication type:
- journal article
JS-K, a GST-activated nitric oxide donor prodrug, enhances chemo-sensitivity in renal carcinoma cells and prevents cardiac myocytes toxicity induced by Doxorubicin.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Differential effects of thiopurine methyltransferase (TPMT) and multidrug resistance-associated protein gene 4 (MRP4) on mercaptopurine toxicity.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague-Dawley rats.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Visfatin mediates doxorubicin resistance in human colorectal cancer cells via up regulation of multidrug resistance 1 (MDR1).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Eribulin shows high concentration and long retention in xenograft tumor tissues.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Human microdosing and mice xenograft data of AGM-130 applied to estimate efficacious doses in patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Does "OPTINAB" strategy ("stop-and-go") work in treatment of advanced pancreatic cancer (APC) with nab-paclitaxel-gemcitabine?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Consolidation hyperthermic intraperitoneal chemotherapy for the treatment of advanced stage ovarian carcinoma: a 3 year experience.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2017, v. 80, n. 2, p. 405, doi. 10.1007/s00280-017-3376-8
- By:
- Publication type:
- Article
Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies.
- Published in:
- 2017
- By:
- Publication type:
- journal article